As of the morning of March 29, according to incomplete statistics, among the 38 listed pharmaceutical companies that have published the 2015 annual report, in 2015, the highest operating income was Shanghai Pharmaceuticals, reaching 105.517 billion yuan, and Shanghai Pharmaceuticals successfully squeezed into 100 billion yuan. club. In addition, the operating income of over 10 billion is also the same as Sinopharm, Huadong Pharmaceutical, China Pharmaceutical, Baiyunshan, Harbin Pharmaceutical, Tasly, Sinopharm, Renfu Medicine.
In terms of the net profit attributable to listed companies, Shanghai Pharmaceuticals ranked ahead of 38 pharmaceutical companies with 2.877 billion yuan. The net profit of Tasly, Shanghai Lai Shi, Baiyun Mountain, Xinlitai and Huadong Medicine all exceeded 1 billion yuan.
In terms of growth rate, the performance in 2015 is more surprising and there are many. For example, although the operating income of Tibet Pharmaceuticals declined in 2015, its net profit increased by 336.78%. Also. Shanghai Lai's operating income and net profit both increased significantly, reaching 52.55% and 182.35% respectively. The increase in net profit of Harbin Pharmaceutical Co., Ltd. is also as high as 134.77%.
Some people are happy that some of the 38 pharmaceutical companies, in terms of operating income, Harbin Pharmaceutical, People Tongtai, North China Pharmaceutical, China Resources Shuanghe and other 10 companies have experienced negative growth, accounting for more than a quarter; and in terms of net profit, 9 companies such as China Resources Shuanghe, Puluo Pharmaceutical, Xiangxue Pharmaceutical and Tianmu Pharmaceuticals experienced negative growth, of which Tianmu Pharmaceutical's net profit decreased by 893.97% year-on-year, and Northeast Pharmaceutical's decline also reached 54.41%.
Lh Ovulation Strip,Lh Ovulation Cassette,Ovulation Rapid Test Strip,Diagnostic LH Ovulation Test Kits
Weihai Kangzhou Biotechnology Engineering Co.,Ltd , https://www.weihaikangzhou.com